Use of angiotensin converting enzyme inhibitors (ACEi) and angiotensin II receptor blockers (ARB) are safe in the early post transplant (TPX) period.

被引：0
|
作者：
Formica, RN
Margaryan, A
Friedman, AL
Basadonna, GP
Lorber, MI
Bia, MJ
机构：
[1] Yale Univ, Sch Med, Dept Med, Nephrol Sect, New Haven, CT 06510 USA
[2] Yale Univ, Sch Med, Dept Surg, Sect Organ Transplantat & Immunol, New Haven, CT 06510 USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2002年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：563A / 563A
页数：1
相关论文
共 50 条
  • [1] Pharmacogenetics of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin II receptor blockers (ARB) in cardiovascular diseases
    Agostini, Livia da Cunha
    Silva, Nayara Nascimento Toledo
    Belo, Vanessa de Almeida
    Luizon, Marcelo Rizzatti
    Lima, Angelica Alves
    da Silva, Glenda Nicioli
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2024, 981
  • [2] Early Use of Angiotensin-Converting Enzyme Inhibitors (ACEI) and Angiotensin Receptor Blockers (ARB) Is Associated with Severe Hyperkalemia in Kidney Transplant Recipients.
    Lu, L. H.
    Ueda, K.
    Miguel, M.
    Patel, P.
    Warvariv, V.
    Bohannon, L.
    Bry, W.
    Mahanty, H.
    Hassoun, A.
    Katznelson, S.
    Peddi, V. R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 374 - 374
  • [3] Angiotensin converting enzyme inhibitors (ACEI), angiotensin receptor blockers (ARB) and diuretics for refractory proteinuria.
    Esnault, VLM
    Ekhlas, A
    Nguyen, JM
    Delcroix, C
    Moutel, MG
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 762A - 762A
  • [4] Bradykinin (BK) metabolism in hemodialysis (HD): Comparison of angiotensin converting enzyme inhibitors (ACEi) and angiotensin II receptor Blockers (ARB).
    Ball, AM
    Murphey, LJ
    Pascual, TT
    Brown, NJ
    Ahmad, S
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 712A - 713A
  • [5] Pretreatment with Angiotensin Converting Enzyme Inhibitors (ACEI) or Angiotensin Receptor Blockers (ARB) Reduce Stroke Severity at Presentation
    Morris, Jane G.
    Kane, Kevin
    Fisher, Marc
    STROKE, 2009, 40 (04) : E128 - E128
  • [6] Angiotensin Converting Enzyme Inhibitor (ACEI)/Angiotensin II Receptor Blockers (ARB) and Pneumonia Risk among Stroke Patients
    Liu, Chia-Lin
    Shau, Wen-Yi
    Wu, Chi-Shin
    Lai, Mei-Shu
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S80 - S80
  • [7] Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers used for the treatment of hypertension appear to be safe in the early posttransplant period
    Formica, RN
    Friedman, AL
    Lorber, MI
    Bia, MJ
    TRANSPLANTATION PROCEEDINGS, 2004, 36 (09) : 2675 - 2678
  • [8] Beneficial effect of combination therapy with angiotensin converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) on proteinuria in pediatric patients
    Mucci, T
    Frank, R
    Vento, S
    Gauthier, B
    Vergara, M
    Trachtman, H
    PEDIATRIC RESEARCH, 2004, 55 (04) : 572A - 572A
  • [9] Improved Outcomes in Septic Shock With Pre-hospitalization Use of Angiotensin-converting Enzyme Inhibitors (ACEI) and Angiotensin Receptor Blockers (ARB)
    Mawri, Sagger
    Shah, Jainil
    Tarun, Jain
    Dirani, Rami
    Michaels, Alexander
    Gibbs, Joseph
    Sudasena, Daryl
    Alsafadi, Yasser
    Sengupta, Ruchira
    Albashaireh, Derar
    Ananthasubramaniam, Karthik
    CIRCULATION, 2015, 132
  • [10] Combined angiotensin converting enzyme inhibitor/angiotensin receptor blocker (ACEI/ARB) therapy is safe and effective in kidney transplant patients
    Reilly, James B.
    Goral, Simin
    Bloom, Roy D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 533 - 533
12345